{
    "Trade/Device Name(s)": [
        "Oxycodone Enzyme Immunoassay",
        "Oxycodone Calibrators",
        "Oxycodone Controls",
        "LZI Oxycodone Assay"
    ],
    "Submitter Information": "Lin-Zhi International, Inc.",
    "510(k) Number": "K050733",
    "Predicate Device Reference 510(k) Number(s)": [
        "K040411"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG",
        "DLJ",
        "LAS"
    ],
    "Summary Letter Date": "June 13, 2005",
    "Summary Letter Received Date": "May 24, 2005",
    "Submission Date": "May 20, 2005",
    "Regulation Number(s)": [
        "21CFR862.3650",
        "21CFR862.3200",
        "21CFR862.3280"
    ],
    "Regulation Name(s)": [
        "Opiate test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Oxycodone",
        "Oxymorphone"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Automated clinical chemistry analyzers",
        "Hitachi 717 analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Homogeneous enzyme immunoassay",
        "Enzyme immunoassay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for LZI Oxycodone Enzyme Immunoassay and associated calibrators and controls for qualitative and semi-quantitative detection of oxycodone and oxymorphone in human urine.",
    "Indications for Use Summary": "Qualitative and semi-quantitative analysis of oxycodone and oxymorphone in human urine using a homogeneous enzyme immunoassay; calibrators and controls are intended for calibration and validation of the assay.",
    "fda_folder": "Toxicology"
}